The Role of Pneumonia and Secondary Bacterial Infection in Fatal and Serious Outcomes of Pandemic Influenza A(H1N1)pdm09

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2018 Dec 12

PMID 30526505

Citations 163

Authors

Chandini Raina MacIntyre

Abrar Ahmad Chughtai

Michelle Barnes

Iman Ridda

Holly Seale

Renin Toms

Anita Heywood

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to estimate the prevalence of pneumonia and secondary bacterial infections during the pandemic of influenza A(H1N1)pdm09.

Methods: A systematic review was conducted to identify relevant literature in which clinical outcomes of pandemic influenza A(H1N1)pdm09 infection were described. Published studies (between 01/01/2009 and 05/07/2012) describing cases of fatal or hospitalised A(H1N1)pdm09 and including data on bacterial testing or co-infection.

Results: Seventy five studies met the inclusion criteria. Fatal cases with autopsy specimen testing were reported in 11 studies, in which any co-infection was identified in 23% of cases (Streptococcus pneumoniae 29%). Eleven studies reported bacterial co-infection among hospitalised cases of A(H1N1)2009pdm with confirmed pneumonia, with a mean of 19% positive for bacteria (Streptococcus pneumoniae 54%). Of 16 studies of intensive care unit (ICU) patients, bacterial co-infection identified in a mean of 19% of cases (Streptococcus pneumoniae 26%). The mean prevalence of bacterial co-infection was 12% in studies of hospitalised patients not requiring ICU (Streptococcus pneumoniae 33%) and 16% in studies of paediatric patients hospitalised in general or pediatric intensive care unit (PICU) wards (Streptococcus pneumoniae 16%).

Conclusion: We found that few studies of the 2009 influenza pandemic reported on bacterial complications and testing. Of studies which did report on this, secondary bacterial infection was identified in almost one in four patients, with Streptococcus pneumoniae the most common bacteria identified. Bacterial complications were associated with serious outcomes such as death and admission to intensive care. Prevention and treatment of bacterial secondary infection should be an integral part of pandemic planning, and improved uptake of routine pneumococcal vaccination in adults with an indication may reduce the impact of a pandemic.

Citing Articles

Orally Administered Lactobacilli Strains Modulate Alveolar Macrophages and Improve Protection Against Respiratory Superinfection.

Albarracin L, Dentice Maidana S, Fukuyama K, Elean M, Arganaraz Aybar J, Suda Y Biomolecules. 2025; 14(12.

PMID: 39766307 PMC: 11674826. DOI: 10.3390/biom14121600.

Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections.

Cardoso K, de Souza L, da Silva Santos B, de Carvalho K, da Silva Messias S, de Faria Goncalves A NPJ Vaccines. 2024; 9(1):246.

PMID: 39702744 PMC: 11659394. DOI: 10.1038/s41541-024-01033-5.

Diagnostic value of ultrasound for community-acquired pneumonia in children and its correlation with serum PCT level and PCIS.

Liu Q, Feng Z, Huang K, Yang Z, Xu L, Shen Y Medicine (Baltimore). 2024; 103(43):e39590.

PMID: 39470492 PMC: 11521007. DOI: 10.1097/MD.0000000000039590.

Bacterial co-infection in COVID-19: a call to stay vigilant.

Liu S, Yu C, Tu Q, Zhang Q, Fu Z, Huang Y PeerJ. 2024; 12:e18041.

PMID: 39308818 PMC: 11416760. DOI: 10.7717/peerj.18041.

Fungal coinfection/superinfection in COVID-19 patients in a tertiary hospital in Mexico.

Garcia-Salazar E, Benavidez-Lopez S, Bonifaz A, Hernandez-Mendoza E, Ramirez-Magana X, Reyes-Montes M Biomedica. 2024; 44(3):328-339.

PMID: 39241240 PMC: 11500677. DOI: 10.7705/biomedica.7251.

References

Champunot R, Tanjatham S, Kerdsin A, Puangpatra P, Wangsai S, Treebuphachatsakul P . Impact of pandemic influenza (H1N1) virus-associated community-acquired pneumonia among adults in a tertiary hospital in Thailand. Jpn J Infect Dis. 2010; 63(4):251-6. View

Pecavar B, Nadrah K, Papst L, Cec V, Kotar T, Maticic M . Clinical characteristics of adult patients with influenza-like illness hospitalized in general ward during Influenza A H1N1 pandemic 2009/2010. Wien Klin Wochenschr. 2011; 123(21-22):662-7. PMC: 7101784. DOI: 10.1007/s00508-011-0054-4. View

Busi Rizzi E, Schinina V, Ferraro F, Rovighi L, Cristoforo M, Chiappetta D . Radiological findings of pneumonia in patients with swine-origin influenza A virus (H1N1). Radiol Med. 2010; 115(4):507-15. PMC: 7101976. DOI: 10.1007/s11547-010-0553-9. View

Louie J, Gavali S, Acosta M, Samuel M, Winter K, Jean C . Children hospitalized with 2009 novel influenza A(H1N1) in California. Arch Pediatr Adolesc Med. 2010; 164(11):1023-31. DOI: 10.1001/archpediatrics.2010.203. View

Martin-Loeches I, Sanchez-Corral A, Diaz E, Granada R, Zaragoza R, Villavicencio C . Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2010; 139(3):555-562. DOI: 10.1378/chest.10-1396. View

Chien Y, Klugman K, Morens D . Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med. 2009; 361(26):2582-3. DOI: 10.1056/NEJMc0908216. View

Muscatello D, Cretikos M, MacIntyre C . All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009. Emerg Infect Dis. 2010; 16(9):1396-402. PMC: 3294965. DOI: 10.3201/eid1609.091723. View

Miller 3rd R, Markewitz B, Rolfs R, Brown S, Dascomb K, Grissom C . Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest. 2009; 137(4):752-8. PMC: 3198489. DOI: 10.1378/chest.09-2517. View

Koegelenberg C, Irusen E, Cooper R, Diacon A, Taljaard J, Mowlana A . High mortality from respiratory failure secondary to swine-origin influenza A (H1N1) in South Africa. QJM. 2010; 103(5):319-25. DOI: 10.1093/qjmed/hcq022. View

10.

Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N . Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009; 302(17):1888-95. DOI: 10.1001/jama.2009.1535. View

11.

Myles P, Semple M, Lim W, Openshaw P, Gadd E, Read R . Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax. 2012; 67(8):709-17. PMC: 3402749. DOI: 10.1136/thoraxjnl-2011-200266. View

12.

Parakh A, Kumar A, Kumar V, Dutta A, Khare S . Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1): an experience from a tertiary care center in north India. Indian J Pediatr. 2010; 77(9):981-5. PMC: 7100775. DOI: 10.1007/s12098-010-0168-0. View

13.

Gill J, Sheng Z, Ely S, Guinee D, Beasley M, Suh J . Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med. 2010; 134(2):235-43. PMC: 2819217. DOI: 10.5858/134.2.235. View

14.

To K, Wong S, Li I, Hung I, Tse H, Woo P . Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection. Postgrad Med J. 2010; 86(1019):515-21. PMC: 10017011. DOI: 10.1136/pgmj.2009.096206. View

15.

Santa-Olalla Peralta P, Cortes-Garcia M, Vicente-Herrero M, Castrillo-Villamandos C, Arias-Bohigas P, Pachon-del Amo I . Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April - December 2009. Euro Surveill. 2010; 15(38). DOI: 10.2807/ese.15.38.19667-en. View

16.

. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(27):749-52. View

17.

Kopel E, Amitai Z, Grotto I, Kaliner E, Volovik I . Patients with pandemic (H1N1) 2009 in intensive care units, Israel. Emerg Infect Dis. 2010; 16(4):720-1. PMC: 3321970. DOI: 10.3201/eid1604.091696. View

18.

Dhanoa A, Fang N, Hassan S, Kaniappan P, Rajasekaram G . Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection. Virol J. 2011; 8:501. PMC: 3217982. DOI: 10.1186/1743-422X-8-501. View

19.

Kim H, Kim J, Shin S, Kang Y, Lee H, Kim J . Fatal cases of 2009 pandemic influenza A (H1N1) in Korea. J Korean Med Sci. 2011; 26(1):22-7. PMC: 3012845. DOI: 10.3346/jkms.2011.26.1.22. View

20.

Chien Y, Su C, Tsai H, Huang A, Lien C, Hung M . Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect. 2009; 60(2):168-74. DOI: 10.1016/j.jinf.2009.12.012. View